https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-may-13-2026/ 2026-05-13T20:01:08Z Pharminent en Manufacturing Intelligence • Weekly Digest • May 13, 2026 2026-05-13T20:01:04Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-may-13-2026/ 2026-05-13T18:19:27Z Pharminent en Strategic News Watch • May 13, 2026 2026-05-13T18:19:23Z Blog https://pharminent.com/uniqure-replimune-shares-rise-as-fdas-makary-exits-but-path-forward-unchanged/ 2026-05-13T18:28:09Z Pharminent en UniQure, Replimune shares rise as FDA's Makary exits, but path forward unchanged 2026-05-13T15:08:13Z Blog https://pharminent.com/assertio-accepts-new-buyout-bid-ai-biotech-isomorphic-banks-2b/ 2026-05-13T18:28:12Z Pharminent en Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B 2026-05-13T14:27:40Z Blog https://pharminent.com/80624-2/ 2026-05-14T01:15:32Z Pharminent en 2026-05-13T01:14:45Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-may-12-2026/ 2026-05-12T23:29:24Z Pharminent en Oncology Intelligence Digest • May 12 2026 2026-05-12T23:29:20Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-may-12-2026/ 2026-05-12T23:03:30Z Pharminent en Strategic News Watch • May 12, 2026 2026-05-12T23:03:27Z Blog https://pharminent.com/80501-2/ 2026-05-12T13:06:45Z Pharminent en 2026-05-12T13:06:40Z Blog https://pharminent.com/bms-hengrui-build-13-asset-pipeline-in-15b-onco-immune-deal/ 2026-05-12T16:29:30Z Pharminent en BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal 2026-05-12T12:19:31Z Blog https://pharminent.com/eu-agrees-plan-to-tackle-essential-medicine-shortages/ 2026-05-12T16:29:34Z Pharminent en EU agrees plan to tackle essential medicine shortages 2026-05-12T12:09:07Z Blog https://pharminent.com/bridgebio-stands-up-to-pfizer-in-attr-cm-as-late-stage-data-hint-at-better-survival/ 2026-05-12T16:29:35Z Pharminent en BridgeBio stands up to Pfizer in ATTR-CM as late-stage data hint at better survival 2026-05-12T11:34:15Z Blog https://pharminent.com/novo-says-high-dose-wegovy-can-cause-28-weight-loss/ 2026-05-12T16:29:37Z Pharminent en Novo says high-dose Wegovy can cause 28% weight loss 2026-05-12T11:01:53Z Blog https://pharminent.com/340b-in-2026-market-shifts-policy-battles-and-what-they-mean-for-stakeholders-new-live-video-webinar/ 2026-05-12T16:29:39Z Pharminent en 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar) 2026-05-12T10:30:00Z Blog https://pharminent.com/cellular-intelligence-scoops-up-novos-parkinsons-therapy/ 2026-05-12T16:21:17Z Pharminent en Cellular Intelligence scoops up Novo's Parkinson's therapy 2026-05-12T08:37:02Z Blog